These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3582069)

  • 1. An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine.
    Beisker W; Dolbeare F; Gray JW
    Cytometry; 1987 Mar; 8(2):235-9. PubMed ID: 3582069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochemistry for bromodeoxyuridine/DNA analysis: stoichiometry and sensitivity.
    Dolbeare F; Beisker W; Pallavicini MG; Vanderlaan M; Gray JW
    Cytometry; 1985 Nov; 6(6):521-30. PubMed ID: 4064837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous flow cytometric detection of cellular c-myc protein, incorporated bromodeoxyuridine, and DNA.
    Rosette CD; DeTeresa PS; Pallavicini MG
    Cytometry; 1990; 11(4):547-51. PubMed ID: 2111761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of denaturation with HCl on the immunological staining of bromodeoxyuridine incorporated into DNA.
    Sasaki K; Adachi S; Yamamoto T; Murakami T; Tanaka K; Takahashi M
    Cytometry; 1988 Jan; 9(1):93-6. PubMed ID: 2457476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thermal denaturation of DNA for immunochemical staining of incorporated bromodeoxyuridine (BrdUrd): critical factors that affect the amount of fluorescence and the shape of BrdUrd/DNA histogram.
    Hoy CA; Seamer LC; Schimke RT
    Cytometry; 1989 Nov; 10(6):718-25. PubMed ID: 2582962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved method for the immunocytochemical detection of bromodeoxyuridine labeled nuclei using flow cytometry.
    Schutte B; Reynders MM; van Assche CL; Hupperets PS; Bosman FT; Blijham GH
    Cytometry; 1987 Jul; 8(4):372-6. PubMed ID: 3113895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using monoclonal antibodies in bromodeoxyuridine-DNA analysis.
    Dolbeare F; Kuo WL; Beisker W; Vanderlaan M; Gray JW
    Methods Cell Biol; 1990; 33():207-16. PubMed ID: 1707484
    [No Abstract]   [Full Text] [Related]  

  • 8. Flow cytometric detection of mitotic cells using the bromodeoxyuridine/DNA technique in combination with 90 degrees and forward scatter measurements.
    Nüsse M; Jülch M; Geido E; Bruno S; Di Vinci A; Giaretti W; Ruoss K
    Cytometry; 1989 May; 10(3):312-9. PubMed ID: 2496957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescent evaluation of DNA repair synthesis using interactive laser cytometry.
    Srivastava V; Miller S; Busbee D
    Cytometry; 1993; 14(2):144-53. PubMed ID: 8440148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of an ELISA procedure for the quantitation of bromodeoxyuridine incorporated into cellular DNA.
    Cheitlin RA; Bodell WJ
    Anticancer Res; 1988; 8(3):471-4. PubMed ID: 3389750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunocytochemical detection methods of incorporated bromodeoxyuridine in hybridomas.
    Williams LS; Nordberg JA; Chau PC
    Cytometry; 1990; 11(4):490-7. PubMed ID: 2111760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A method to measure the duration of DNA synthesis and the potential doubling time from a single sample.
    Begg AC; McNally NJ; Shrieve DC; Kärcher H
    Cytometry; 1985 Nov; 6(6):620-6. PubMed ID: 4064842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid flow cytometric method for bivariate bromodeoxyuridine/DNA analysis using simultaneous proteolytic enzyme digestion and acid denaturation.
    van Erp PE; Brons PP; Boezeman JB; de Jongh GJ; Bauer FW
    Cytometry; 1988 Nov; 9(6):627-30. PubMed ID: 2463135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle analysis using numerical simulation of bivariate DNA/bromodeoxyuridine distributions.
    Yanagisawa M; Dolbeare F; Todoroki T; Gray JW
    Cytometry; 1985 Nov; 6(6):550-62. PubMed ID: 4064838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of mitotic melanoma cells from G2 cells and their isolation by use of 5-bromo-2'-deoxyuridine and propidium iodide.
    Trinkle LS; Swope VB; Abdel-Malek ZA; Nordlund JJ
    Cytometry; 1988 Sep; 9(5):432-5. PubMed ID: 3180943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay.
    Waldman FM; Dolbeare F; Gray JW
    Cytometry; 1985 Nov; 6(6):657-62. PubMed ID: 4064845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of S cells and evaluation of DNA denaturation protocols by image cytometry of fluorescent BrdUrd labelling.
    Humbert C; Giroud F; Brugal G
    Cytometry; 1990; 11(4):481-9. PubMed ID: 2188816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination of bromodeoxyuridine labelled and unlabelled mitotic cells in flow cytometric bromodeoxyuridine/DNA analysis.
    Jensen PO; Larsen JK; Christensen IJ; van Erp PE
    Cytometry; 1994 Feb; 15(2):154-61. PubMed ID: 8168402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrochloric acid denaturation of colorectal tumour tissue infiltrated with bromodeoxyuridine.
    Williamson K; Gilliland R; Weir H; Grimes J; Hamilton P; Anderson N; Crockard A; Rowlands B
    Cytometry; 1994 Feb; 15(2):162-8. PubMed ID: 8168403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of bromodeoxyuridine incorporation by alteration of the fluorescence emission from nucleic acid binding dyes using only an argon ion laser.
    Frey T
    Cytometry; 1994 Dec; 17(4):310-8. PubMed ID: 7875038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.